Company intelligence / Profile preview

Capital Pacific

Menlo Park, California, USA

Ownership: Private
Employees: ~575
Development stage: Other

Overview

Pacific Biosciences (PacBio) develops and manufactures advanced long-read sequencing systems and consumables based on its proprietary Single-Molecule Real-Time (SMRT) technology. Their products are primarily used for research in human genomics, cancer genomics, microbial genomics, and other life science applications, operating on a 'razor-and-blade' business model.

Modalities: Device
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Capital Pacific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capital Pacific.

Explore the full profile